These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 34710243
1. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. Troussard X, Maître E, Cornet E. Am J Hematol; 2022 Feb 01; 97(2):226-236. PubMed ID: 34710243 [Abstract] [Full Text] [Related]
2. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. Troussard X, Maître E, Paillassa J. Am J Hematol; 2024 Apr 01; 99(4):679-696. PubMed ID: 38440808 [Abstract] [Full Text] [Related]
3. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Maitre E, Cornet E, Troussard X. Am J Hematol; 2019 Dec 01; 94(12):1413-1422. PubMed ID: 31591741 [Abstract] [Full Text] [Related]
4. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. Troussard X, Cornet E. Am J Hematol; 2017 Dec 01; 92(12):1382-1390. PubMed ID: 29110361 [Abstract] [Full Text] [Related]
5. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Cornet E, Delmer A, Feugier P, Garnache-Ottou F, Ghez D, Leblond V, Levy V, Maloisel F, Re D, Zini JM, Troussard X, French Society of Haematology. Ann Hematol; 2014 Dec 01; 93(12):1977-83. PubMed ID: 24994538 [Abstract] [Full Text] [Related]
6. Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group. Paillassa J, Maitre E, Belarbi Boudjerra N, Madani A, Benlakhal R, Matthes T, Van Den Neste E, Cailly L, Inchiappa L, Bekadja MA, Tomowiak C, Troussard X. Cancers (Basel); 2024 Jun 10; 16(12):. PubMed ID: 38927891 [Abstract] [Full Text] [Related]
11. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Paillassa J, Maitre E, Troussard X. Curr Oncol Rep; 2022 Sep 30; 24(9):1133-1143. PubMed ID: 35403971 [Abstract] [Full Text] [Related]
12. Novel therapeutic options for relapsed hairy cell leukemia. Jain P, Polliack A, Ravandi F. Leuk Lymphoma; 2015 Sep 30; 56(8):2264-72. PubMed ID: 25563425 [Abstract] [Full Text] [Related]
13. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant]. Wei C, Jin XX, Cai H, Wang X, Zhuang JL, Zhou DB. Zhonghua Nei Ke Za Zhi; 2023 Apr 01; 62(4):416-421. PubMed ID: 37032137 [Abstract] [Full Text] [Related]
15. Update on the biology and treatment options for hairy cell leukemia. Jain P, Pemmaraju N, Ravandi F. Curr Treat Options Oncol; 2014 Jun 01; 15(2):187-209. PubMed ID: 24652320 [Abstract] [Full Text] [Related]
16. BRAF V600E mutation in hairy cell leukemia: from bench to bedside. Falini B, Martelli MP, Tiacci E. Blood; 2016 Oct 13; 128(15):1918-1927. PubMed ID: 27554081 [Abstract] [Full Text] [Related]
17. Bone marrow and splenic histology in hairy cell leukaemia. Wotherspoon A, Attygalle A, Mendes LS. Best Pract Res Clin Haematol; 2015 Dec 13; 28(4):200-7. PubMed ID: 26614898 [Abstract] [Full Text] [Related]
18. Update on hairy cell leukemia. Kreitman RJ, Arons E. Clin Adv Hematol Oncol; 2018 Mar 13; 16(3):205-215. PubMed ID: 29742076 [Abstract] [Full Text] [Related]
19. [Novelties in the diagnostics and therapy of hairy cell leukemia]. Sári E, Rajnai H, Dénes K, Bödör C, Csomor J, Körösmezey G, Tárkányi I, Eid H, Nagy Z, Demeter J. Magy Onkol; 2016 Jun 06; 60(2):137-44. PubMed ID: 27275640 [Abstract] [Full Text] [Related]
20. New treatment options in hairy cell leukemia with focus on BRAF inhibitors. Falini B, Tiacci E. Hematol Oncol; 2019 Jun 06; 37 Suppl 1():30-37. PubMed ID: 31187521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]